![UBS lifts its 2025 gold price forecast. Here's the new target](https://i-invdn-com.investing.com/news/LYNXNPEB8N174_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.330 | 4.180 | 0.850 |
Stocks | 96.660 | 96.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.204 | 19.779 |
Price to Book | 2.636 | 4.043 |
Price to Sales | 1.497 | 2.422 |
Price to Cash Flow | 12.425 | 16.160 |
Dividend Yield | 1.958 | 1.381 |
5 Years Earnings Growth | 8.272 | 12.141 |
Number of long holdings: 53
Number of short holdings: 7
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 5.14 | 11,656.0 | -0.44% | |
Novartis | CH0012005267 | 4.46 | 95.64 | +0.28% | |
UCB | BE0003739530 | 4.32 | 182.60 | +1.19% | |
Pfizer | US7170811035 | 4.25 | 25.53 | -0.43% | |
Siemens Healthineers | DE000SHL1006 | 4.12 | 57.44 | +0.24% | |
Medtronic | IE00BTN1Y115 | 3.76 | 92.81 | +0.66% | |
Baxter | US0718131099 | 3.74 | 30.82 | +0.65% | |
BeiGene ADS | US07725L1026 | 3.68 | 230.86 | +2.38% | |
Biomarin Pharma | US09061G1013 | 3.67 | 64.85 | +0.67% | |
Lonza Group | CH0013841017 | 3.66 | 601.60 | +1.04% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1781816530 | 2.48B | 3.85 | 11.60 | - | ||
EdR Fund Big Data N EUR | 2.48B | 3.88 | 12.18 | - | ||
EdR Fund Big Data R EUR | 2.48B | 4.16 | 10.51 | - | ||
EdR Fund Big Data I EUR | 2.48B | 19.90 | 9.70 | - | ||
EdR Fund Big Data A EUR | 2.48B | 4.20 | 10.99 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review